The widely used organophosphorus compound tri-o-cresyl phosphate (TOCP) elicits delayed neurotoxicity characterized by progressive axonal degeneration in the spinal cord and peripheral nerves. However, the precise mechanisms of TOCP-induced delayed neurotoxicity are not clear. Because autophagy has been linked to the pathogenesis of neurodegenerative diseases, we aimed to characterize autophagy in the progression of TOCPinduced delayed neurotoxicity. In vivo experiments using the adult hen animal model showed that autophagy in spinal cord axons and in sciatic nerves was markedly induced at the early preclinical stage of TOCP-induced delayed neurotoxicity; it was decreased as the delayed neurotoxicity progressed to the overt neuropathy stage. In cultured human neuroblastoma SH-SY5Y cells, TOCP reduced cell growth, and induced prominent autophagy. The autophagy inhibitor 3-methyladenine could attenuate TOCP-induced cytotoxicity, indicating that the autophagy is accountable for TOCP-induced neurotoxicity. In addition, we found that TOCP-induced Parkin translocation to mitochondria in SH-SY5Y cells, suggesting that autophagy may function to degrade mitochondria after TOCP exposure. These results suggest that autophagy may play an important role in the initiation and progression of axonal damage during TOCP-induced neurotoxicity.
INTRODUCTION
The organophosphate tri-o-cresyl phosphate (TOCP) has been widely used as a plasticizer, plastic softener, flame-retardant, and jet oil additive (1, 2) . This compound is capable of inducing a delayed neurotoxicity in humans, birds, and other sensitive animals. TOCP was used as cheaper substitute for molasses or castor oil in "Ginger Jake," which caused delayed neurotoxicity in estimated 50 000 people in the United States in 1930s (3, 4) . Cooking oil contaminated with lubricating oil, which contained TOCP, led to paralysis of thousands of individuals in Morocco, Holland, Fiji, Yugoslavia, France, South Africa, Sri Lanka, and India (5) . In northern suburbs of Xi'an in China, TOCP contaminated flour lead to 74 patients paralyzed (6) . The latent period is at least 1 week after exposure before the onset of progressive hind limb ataxia and paralysis, accompanied by distal degeneration of long and large-diameter axons in the sciatic nerve and spinal cord (7) . The manifestation of the delayed neurotoxicity is species-sensitive and age-dependent. Adult hens have been extensively used as the animal model for experimental studies because of their sensitivity to TOCP and the similarity of the clinical signs of the delayed neurotoxicity in hens to those seen in humans (8, 9) . In contrast, rodents, particularly mice, are refractory to TOCP-induced delayed neurotoxicity (10, 11) . Although the delayed neurotoxicity has been the subject of intense investigation since its discovery, the molecular mechanisms underlying its pathology remain poorly understood.
Autophagy, the degradation of large amount of cytoplasmic components, occurs under both normal and stress conditions. Autophagy has been linked to the pathogenesis of neurodegenerative diseases (12) . Whether the pathogenesis of TOCP-induced delayed neuropathy, as one type of neurodegenerative disease, is related to autophagy is not clear. A previous study in our lab found that autophagy induced by exposure to 0.5 and 1 mM TOCP for 24 in differentiated SH-SY5Y cells lead to degradation of cytoskeletal components and inhibition of neurite outgrowth (13) ; this indicated that pathologic degradation of protein or organelles by autophagy in neurons blocks the differentiation of neurons.
We carried out in vivo experiments to examine whether autophagy occurs in hens treated with TOCP. To investigate the mechanism of autophagy induced by TOCP further, we used the cultured neuroblastoma cell line SH-SY5Y as an in vitro model because these cells have been widely used to investigate organophosphate-induced neurotoxicity (13) (14) (15) .
Our results indicate that autophagy may play an important role in the initiation and progression of axonal damage in neurons during TOCP-induced neurotoxicity.
MATERIALS AND METHODS

Animal Treatment and Sampling
Adult Beijing white laying hens (8-month-old and $1.5 kg in weight) were purchased from the Beijing Fujia Center for Breeding Birds (Beijing, China). Thirty-five hens were assigned into four experimental groups and 1 control group (n ¼ 7 for all groups). Birds were acclimatized for at least 1 week prior to the start of the experiment. Hens in the TOCP-treated groups were given a single dose of 750 mg/kg body weight TOCP (purity >99%, BDH Chemicals, London, UK), in a gelatin capsule by oral gavage, whereas hens in control group were given an empty gelatin capsule. The temperature in the hen house was maintained at 22 C and 50% humidity with a light/dark cycle of 12 hours. All animal procedures were performed in accordance with current Chinese legislation and approved by the Chinese Academy of Sciences Institute of Zoology's Animal and Medical Ethics Committee.
After exposure to TOCP, the hens were examined daily for neurotoxic signs. Four hens from each experimental group were killed by cervical decapitation on days 2, 7, 14, and 21 after TOCP treatment. The spinal cord and sciatic nerves were quickly dissected and frozen in liquid nitrogen before being stored at À80 C for biochemical analysis. Three hens from each experimental group and control group at each time point were anesthetized by intraperitoneal injection of sodium pentobarbital (60 mg/kg body weight) and perfused with 4% paraformaldehyde for collecting samples for immunohistochemistry. The perfused spinal cord and sciatic nerve tissues were post-fixed in 4% paraformaldehyde for 24 hours at 4 C, after which they were cryoprotected by storage in 0.1M phosphate buffer solution (pH 7.4) (PBS) containing 30% sucrose at 4 C for 2 days. The spinal cord was cut into 15-lm coronal sections on a cryostat and the sciatic nerve 10-lm coronal sections and longitudinal sections.
Cell Culture and Treatments
The human neuroblastoma cell line SH-SY5Y (CAMS Cell Center, Beijing, China) was maintained in Dulbecco's modified Eagle's medium (Sigma, St. Louis, MO) complemented with 10% fetal calf serum (Chuanye Biosciences, Tianjin, China), 100 IU/ml penicillin, and 100 mg/ml streptomycin. Incubations were carried out at 37 C in a humidified atmosphere of 5% CO 2 /95% air. The cells were grown at a density of 1 Â 10 6 cells per 100-mm culture dish. SH-SY5Y cells were cultured in 96 wells and then treated with 0.25mM or 1 mM TOCP for 24 hours. One mM 3-methyladenine ( , an autophagy inhibitor) (Sigma), 1 nM bafilomycin A1 ([Baf A1], an inhibitor of the fusion between autophagosomes and lysosomes) (J & K Scientific, Beijing, China) were added to culture media 2 hours prior to TOCP treatment. Cell growth was determined by the crystal violet assay, as described earlier (16) .
Immunofluorescence
All spinal cord and sciatic nerve sections were fixed in 4% paraformaldehyde in PBS for 10 minutes, washed 3 times with PBS, permeabilized with 0.5% Triton X-100 in PBS for 10 minutes and blocked with 10% bovine serum albumin (BSA) (Sigma) in PBS for 1 hours. Sections were incubated for 2 hours with primary antibodies diluted in 10% BSA in PBS followed by incubation with secondary antibodies diluted in 10% BSA in PBS for 1 hour. Nuclei were stained with Hoechst 33258 (Sigma) for 5 minutes. Coverslips were mounted onto microscope slides using fluorescent mounting medium.
Isolation of Mitochondrial and Cytosolic Fractions
Mitochondrial and cytosolic fractions were prepared by differential centrifugation at 4 C (17). The cell pellets were washed twice with PBS and resuspended in HEPES buffer (20 mM HEPES, pH 7.2, 210 mM sucrose, 70 mM mannitol, 10 mM KCl, 1 mM DTT, 1 mM EDTA, 1 mM EGTA, 5 mg/ml of aprotinin, pepstatin, and leupeptin, and 1 mM PMSF). The cells were homogenized in HEPES buffer and then centrifuged twice at 600g for 10 minutes. The supernatant was centrifuged at 12 000g for 15 minutes and the mitochondria in the pellets were washed and resuspended in HEPES buffer. The resultant mitochondria fraction and cytosolic fraction (the supernatant) were used to examine the translocation of Parkin from cytoplasm to mitochondria by Western blotting analysis.
Protein Expression Analysis
For Western blotting analysis, the homogenized tissues and cells were lysed in modified RIPA buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, 5 mM sodium fluoride, 1 mM sodium ortho vanadate, 1 mM EDTA, 5 mg/ml of aprotinin, pepstatin, and leupeptin, 1 mM PMSF). Tissue and cell debris were pelleted at 14 000g at 4 C for 15 minutes. The protein was boiled for 5 minutes at 100 C and separated by SDS-PAGE, then transferred to a polyvinylidene fluoride membrane (Millipore, Billerica, MA). Following transfer, membranes were blocked with 1Â Tris-buffered saline containing 0.1% Tween-20 and 5% non-fat milk for at least 1 h, then incubated with primary antibodies overnight at 4 C, followed by incubation with horseradish peroxidase-conjugated secondary antibodies (Cowin Biotech, Beijing, China) for 1 hour. Immunoreactive bands were detected using a ChemiDoc XRS system (BioRad, Hercules, CA). The Western blotting bands were quantified using Quantity One software (Bio-Rad). The following primary antibodies were used: anti-LC3, and anti-Atg5 
Statistical Analysis
Data were evaluated with a one-way analysis of variance (ANOVA) and a Newman-Keuls multiple range test. P values <0.05 (p < 0.05) and 0.01 (p < 0.01) were considered statistically significant and extremely significant, respectively.
RESULTS
LC3 Immunofluorescence at the Early Stages of TOCP-Induced Neurotoxicity in Hens
Hens exposed to TOCP began to manifest slight incoordination on day 7 and then developed severe ataxia with The expression levels of the Atg5-Atg12 complex, LC3-II, and Beclin-1 in spinal cord (B) and sciatic nerve (C), respectively, were quantified by Quantity One software (n ¼ 7, * and **p < 0.05 and p < 0.01, respectively, compared with controls). Numbers denote the day on which the spinal cords and sciatic nerves were sampled in hens following exposure to TOCP.
staggering gait on day 13. Most of TOCP-treated hens showed total hind limb paralysis on day 17 and were unable to stand and were completely paralyzed on day 21 (data not shown).
To assess whether autophagy occurred in TOCPinduced delayed neuropathy, immunofluorescence staining for the autophagosome marker LC3 was carried out in spinal cord and sciatic nerves. LC3 expression was distributed homogeneously in the control group, whereas LC3 immunofluorescence in the TOCP treatment group was more prominent and clustered in both spinal cord and sciatic nerves on days 2 and 7 after TOCP exposure. LC3 immunostaining was mainly located in axons in sciatic nerves. In spinal cord, some glial cells were also stained with anti-LC3, particularly on day 2, indicating that autophagy may occur in both neuronal and glial cells. However, autophagy disappeared in both spinal cord and sciatic nerves when the neuropathy worsened from days 14 to 21 (Fig. 1A, B) . These findings indicate that autophagy had been robustly and rapidly activated at the very early stage of the delayed neurotoxicity, and its level maintained when clinical signs began to emerge (at day 7).
Expression of Autophagy-Related Proteins in Hens Treated with TOCP
Western blotting analysis was carried out to detect autophagy-related protein expression in the spinal cord and sciatic nerves. As shown in Figure 2A , expression of the Atg5-Atg12 complex, Beclin-1, and LC3-PE conjugate (LC3-II) significantly increased compared to those of the control group on days 2 and 7 after TOCP treatment (p < 0.01, T2, T7 vs. Con). However, with the exception of the level of LC3-II in spinal cord on day 14, the levels of the autophagy-related protein expression dramatically declined on day 14 and 21 ( Fig. 2B, C) (p < 0.01, T14, T21 vs. Con).
Autophagy Induced by TOCP in SH-SY5Y Cells
To determine whether TOCP could induce autophagy in neuronal cells, we carried out Western blotting analysis of LC3. The result showed enhanced processing of LC3-I to LC3-II following TOCP treatment, indicating that autophagosomes increased after the treatment (Fig. 3A) . The increase of autophagosomes could result from either the increase of autophagosome formation or the inhibition of autophagosome degradation by lysosomes. Thus, we used autophagy inhibitor 3-MA, which inhibits the formation of autophagosomes, and lysosomal inhibitor, Baf A1, which inhibits the fusion of autophagosomes and lysosomes (18, 19) , to determine whether TOCP-induced increase of autophagosomes results from the increased formation of autophagosomes or a defect in the fusion process. The quantitative results showed that 3-MA significantly reduced the level of TOCPinduced LC3-II/LC-I (p < 0.01, TOCP plus 3-MA vs TOCP alone), whereas Baf A1 increased the level of TOCP induced LC3-II/LC-I (p < 0.01, TOCP plus Baf A1 vs TOCP alone) (Fig.  3B) . The combined treatment of Baf A1 and TOCP resulted in much higher processing of LC3-I into LC3-II compared with Baf A1 or TOCP alone treatment, although LC3-II level in the combined treatment group was slightly lower than in the TOCP alone treatment group. Thus, our results revealed that TOCP induced the formation of autophagosomes in neuronal cells.
We next examined whether TOCP-induced autophagy is cytotoxic or protective. The result showed that TOCP significantly inhibited cell growth (p < 0.01, TOCP vs vehicle), while 3-MA, but not Baf A1, reversed TOCP-induced inhibition of cell growth (p < 0.01, TOCP plus 3-MA vs. TOCP alone) ( Fig. 3C) . These results suggest that autophagy induced by TOCP may contribute to the cytotoxicity of TOCP. Meanwhile, we did not observe apoptosis based on the results of nuclei staining as well as flow cytometry (data not shown), which was consistent with the previous studies for the effects of TOCP on rat spermatogonial stem cells (20, 21) . Furthermore, our previous study showed that TOCP did not alter cell cycle regulation after a 24-hour treatment (22) . Thus, TOCP mainly induced autophagic cell death in SH-SY5Y cells via increase of formation of autophagosomes and the accumulation of autophagosomes.
TOCP-Induced Colocalization of Mitochondria with Autophagosomes and Parkin Translocation to Mitochondria
Autophagy can degrade subcellular organelles and a previous study on organophosphate-induced delayed neuropathy (OPIDN) suggested that neuronal mitochondria were a primary target of organophosphates in degenerating neurons, which is an early event in OPIDN (23) (24) (25) . Thus, we then assessed that whether mitochondria were degraded by autophagosomes. We carried out immunofluorescence staining with markers for autophagosomes, mitochondria, and lysosomes in SH-SY5Y cells. LC3 was even distributed in cytoplasm and no colocalization was found between LC3 and mitochondria or lysosomes in control SY5Y cells. However, following a 24-h exposure to 1 mM TOCP, the cells displayed significant overlap between autophagosomes (dotted LC3) and mitochondria (cytochrome C, Cyt c) (Fig. 4,  upper panels) . The mitochondria colocalized with lysosomes (labeled with LysoTracker Red) in the cells with TOCP treatment (Fig. 4, lower panels) .
Because the translocation of Parkin from cytoplasm to mitochondria is required for mitochondria to be engulfed by autophagosomes, we assessed the distribution of Parkin in TOCP-treated cells by immunofluorescence and Western blotting analysis. We found that endogenous Parkin was predominately distributed in the cytosol of the cells treated with vehicle (Fig. 5B, C) . However, it was recruited to mitochondria from the cytoplasm in the majority of cells treated with TOCP (Fig. 5A , lower panel, and 5B) and its level increased in the mitochondria fraction (Fig. 5C) .
The autophagy inhibitor 3-MA attenuated TOCPinduced Parkin translocation from cytoplasm to mitochondria (p < 0.01, TOCP plus 3-MA vs TOCP alone) (Fig. 5D) , whereas 3-MA itself had no effect on Parkin translocation (p > 0.05, 3-MA vs vehicle). However, Baf A1 itself could lead to the translocation of Parkin from cytoplasm to mitochondria (Fig. 5D) , possibly because Baf A1 inhibited the degradation of autophagosomes and resulted in accumulation of damaged mitochondria. Anti-Tom20 and -Tim23 locate mitochondrial outer and inner membrane respectively; these are usually used as markers when labeling mitochondria in mitophagy studies (26) . The Western blotting analysis for Tom20 and Tim23 indicated that TOCP induced the loss of mitochondria, while both 3-MA and Baf A1 could rescue TOCP-induced mitochondria loss (Supplemental Data Fig.  S1 ), indicating that TOCP-induced autophagy could degrade mitochondria.
DISCUSSION
Different hypotheses on the molecular mechanisms of TOCP-induced delayed neurotoxicity have been proposed. It was suggested that TOCP initially caused the inhibition and aging of neuropathy target esterase, which led to the develop- ## and @@ , extremely significant when compared with TOCP alone treatment group and with Baf A1 alone treatment group respectively. Abbreviations: 3-MA, 3-methyladenine; Baf A1, bafilomycin A1; CON, control; Cyt, cytoplasm; Mit, mitochondria; TOCP, tri-o-cresyl phosphate. ment of the delayed neuropathy (27) (28) (29) . Abou-Donia proposed that increased protein kinase-mediated phosphorylation of cytoskeletal proteins could lead to the aggregation and dysregulation of cytoskeleton in axon and the following development of OPIDN (30) . However, the exact mechanisms underlying OPIDN are not yet fully understood. Our results reveal that TOCP induced autophagy in sciatic nerves and spinal cord in adult hens and robust autophagic cell death in cultured neuroblastoma cells.
Extensive autophagy may destroy cellular components, which ultimately results in cell death (19) . We found that the expression levels of the Atg5-Atg12 complex, Beclin-1, and LC3-II in the spinal cord and sciatic nerves of hens were significantly higher than basal levels on days 2 and 7 after TOCP treatment. This indicates that autophagy was probably immediately activated following TOCP administration and that it may peak on day 7. The immunofluorescence results of the spinal cord and sciatic nerves from TOCP-treated hens support the Western blotting results. However, Atg5-Atg12 complex, Beclin-1, and LC3-II levels in TOCP-treated hens had fallen below basal levels on days 14 and 21 and almost no punctate LC3 was observed at these two time points, when the hens were severely paralyzed. These results might suggest that the early hyperactive autophagy following TOCP exposure contributes to the initiation of the delayed neuropathy.
A recent study by Song et al. (31) showed significantly different results from this study,that is increased autophagosomes in myelinated and unmyelinated axons of hen spinal cords were observed at days 10 and 21 after TOCP exposure. However, their results also showed a stronger expression of LC3-II in spinal cords under physiological conditions (the control group), while few autophagosomes were observed under this condition (31) . Those findings apparently contradict the general observation that the amount of LC3-II peaks at the maturation stage of autophagosomes (32) . In contrast, our Western blotting analysis results are more consistent with the results of our immunofluorescence staining.
Previous studies suggest that damage in neuronal mitochondria is an early event during OPIDN pathogenesis (23) (24) (25) . In this study, we found that TOCP induces increased autophagy in SH-SY5Y cells; the colocalization of mitochondria with autophagosomes and translocation of Parkin indicates that autophagy may function to degrade mitochondria. Although some studies have shown that autophagy attenuates the toxic effect of misfolded protein and damaged organelles by degrading them (33) (34) (35) , other researchers found that autophagy could drive the degeneration of axons and dendrites (36) (37) (38) . Results of this study suggested that excessive autophagy occurred mainly in the preclinical stage in OPIDN. We suggest that this might drive the activation of signals leading to TOCP-induced delayed neuropathy. However, further investigations are needed to determine the underlying mechanisms as well as whether autophagy in glial cells plays a role in the neurotoxicity.
In summary, this study provides a new insight into the mechanism underlying the axonopathy in OPIDN. Autophagy may be involved in the initiation and progression of axonal damage in neurons during OPIDN.
